Please assess the completion status of the following clinical trial:

Trial Title: A Study to Determine Effective Prophylaxis and Treatment of Nelfinavir-Associated Diarrhea

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Antiretroviral-naive patients with HIV-1 infection~* not more than 2 loose stools per day or any preexisting or emerging medical condition that would interfere with the evaluation of therapeutic response of the study drug~* No antidiarrheal medication within 7 days prior to entry~Exclusion Criteria:~* Greater than or equal to 2 loose stools per day lasting 2 or more days within 7 days prior to study entry~* Bloody stools within 7 days prior to study entry~* Any unstable or severe intercurrent medical condition, including active opportunistic infections

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): None
- 2 (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).